MINT-GABAPENTIN
MINT PHARMACEUTICALS INC
Quick answers
Is there a shortage of MINT-GABAPENTIN in Canada?
No. There is no current shortage of MINT-GABAPENTIN 300MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
APO-GABAPENTIN
APOTEX INC
Other Products
NEURONTIN
BGP PHARMA ULC
GABAPENTIN
OMNI LABORATORIES DIVISION, WARNER-LAMBERT CANADA INC.
TEVA-GABAPENTIN
TEVA CANADA LIMITED
NTP-GABAPENTIN
TEVA CANADA LIMITED
DOM-GABAPENTIN
DOMINION PHARMACAL
DIN
02408899
Strength
300MG
Dosage Form
CAPSULE
Route
ORAL
Compare with another product →
Shortage History
Other Products from MINT PHARMACEUTICALS INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
300MG · DIN 02480956
10MG · DIN 02468840
25MG · DIN 02468859
400MG · DIN 02524716
800MG · DIN 02524724
200MG · DIN 02524708
70.0MG · DIN 02394871
5MG · DIN 02362651
10MG · DIN 02362678
1MG · DIN 02393573
5MG · DIN 02495449
2.5MG · DIN 02495430